Pelthos Therapeutics Inc. (PTHS) Misses Q1 EPS by 258c
Tweet
Share
E-mailGet Alerts PTHS Hot Sheet
Join SI Premium – FREE
Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q1 EPS of ($3.09), $2.58 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $10.91 million.
For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
- Goldman Sachs Downgrades AAC Technologies Holdings Inc. (2018:HK) (AACAY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
